Accelerated Approval Integrity Act of 2022
Summary
Accelerated Approval Integrity Act of 2022 This bill establishes requirements relating to postapproval studies for drugs that receive accelerated approval for serious or life-threatening diseases or conditions, such as requiring product sponsors to agree in advance to conduct such studies and terminating product approval if certain benchmarks are not met.
Bill status
in committee
1 of 4 stages cleared
Introduction
Mar 2022
Committee Review
Floor Vote
President
Introduced Mar 7, 2022
Last action Mar 8, 2022
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
3
Key actions
0
Committee
2
Mar 8, 2022
Committee
Referred to the Subcommittee on Health.
lower
Mar 7, 2022
Committee
Referred to the House Committee on Energy and Commerce.
lower
Mar 7, 2022
Introduced
Introduced in House
lower
1 primary · 1 co-sponsor
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 6963
Scope: US
Hi! I can help you understand HR 6963. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline